Parkinsons disease (PD) Conference
Home/ Scientific Sessions / Parkinsons disease Conference
Parkinsons disease
Parkinson’s disease (PD) is a long-term brain disorder that is largely related to movement. It develops when some brain nerve cells lose their function or are destroyed, especially those responsible for making a chemical called dopamine. Dopamine helps in controlling smooth, steady body movements. When the brain receives less dopamine, an individual will start to shake, walk slowly, be rigid, or experience difficulties with balance and walking. Fatigue, depression, disturbed sleep, and speech and handwriting changes are also some of the symptoms. Parkinson’s will worsen, but the rate and the type of the symptoms will differ from individual to individual. Even if there is no cure yet, medication, physical therapy, and in some cases surgery (e.g., deep brain stimulation) can alleviate symptoms and improve living. Improved treatments and greater understanding of PD’s cause are looked for by researchers. Early treatment and management enable individuals with Parkinson’s to live active and meaningful lives
Related Sessions
1.Alzheimers and Parkinsons Diseases
2.Neuroimmunology and Neurological Infections
3 – Cognitive Neuroscience and Psychology
4 – Neuroinformatics and Computational Neuroscience
5 – Neurological Disorders
6 – Neurobiology
7 – Molecular Neuroscience
8 – Pediatric Neurology
9 – Clinical Neurology
10 – Translational Neurology
11 – Neurogenetics
12 – Neurodegenerative Diseases
13 – Neuropsychiatry
14 – Neuroscience Research
15 – Neuropharmacology and Novel Drug Development
16 – Neurological Interventions and Surgery
17 – Artificial Intelligence in Neurology and Neurosurgery
18 – Neuro-ophthalmology and Auditory Neurology
19 – Aging and Neurology
20 – Brain Tumors and Neuro-Oncology
21 – Stroke Diagnosis and Management
22 – Epilepsy and Seizure Disorders
23 – Psychiatric and Behavioral Disorders
24 – Neurovascular Disorders
25 – Neurology and Systemic Disorders
26 – Neurodevelopmental Disorders
27 – Cognitive and Memory Disorders
28 – Neuroinflammation and Brain Disorders
29 – Neurological Rehabilitation
31 – Trauma and Neurocritical Care
33 – Cellular and Systems Neuroscience
35 – Advances in Neuroimaging Techniques
37 – Rare and Complex Brain Disorders
30 – Global Challenges and Public Health
32 – Neurotoxicology
34 – Behavioral Neuroscience and Social Neuroscience
36 – Addiction and Mental Health
Scientific Program
Keynote Speaker - Dr. Zhenhuan LIU (Oral Presentation - In-Person)
Nanhai Maternity and Children Hospital Affiliated to Guangzhou University of Chinese Medicine, China
Keynote Speaker - Dr. Magda Tsolaki - Oral Presentation (Virtual)
Emeritus Professor of Neurology, Aristotle Univesrsity of Thessaloniki, Makedonia, Greece, Chair of the Greek Federation of Alzheimer’s Disease
Keynote Speaker - Dr. Tatsuro Mutoh, MD, PhD, FAAN - Oral Presentation (In-Person)
Department of Neurology, Fujita Health University Hospital, Toyoake, Aichi, Japan
Scientific Program
Keynote Speaker - Dr. Zhenhuan LIU (Oral Presentation - In-Person)
Nanhai Maternity and Children Hospital Affiliated to Guangzhou University of Chinese Medicine, China
Keynote Speaker - Dr. Magda Tsolaki - Oral Presentation (Virtual)
Emeritus Professor of Neurology, Aristotle Univesrsity of Thessaloniki, Makedonia, Greece, Chair of the Greek Federation of Alzheimer’s Disease
Keynote Speaker - Dr. Tatsuro Mutoh, MD, PhD, FAAN - Oral Presentation (In-Person)
Department of Neurology, Fujita Health University Hospital, Toyoake, Aichi, Japan
Committee Members
Kenneth B Storey
Carleton University, Canada
Kindy Mark
University of South Florida, United
Thomas J Webster
Interstellar Therapeutics, United States
Tags